Rabia Gurses Ozden insider trades

Open-market stock purchases and sales by Rabia Gurses Ozden, Chief Medical Officer at Adverum Biotechnologies, Inc, from SEC Form 4 filings since Mar 17, 2022.

Recent trades

DateStockTradeValue
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)—
Dec 9, 2025ADVM Adverum Biotechnologies, IncBought (not open market)—
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)—
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)$622K
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)$315K
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)$205K
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)$81.1K
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)$40.6K

Companies traded

  • ADVM Adverum Biotechnologies, Inc: other filings, last Dec 9, 2025
  • OCUL Ocular Therapeutix, Inc: 4 sales, last Feb 5, 2024

Get free alerts when Rabia Gurses Ozden files a new trade →